Paul F. Truex

Paul F. Truex is a declared insider at 3 companies (board member); the most frequent names are Anthera Pharmaceuticals Inc, Milestone Pharmaceuticals Inc. and Trius Therapeutics Inc. In total, 68 filings cover trades dated from 1 March 2010 to 31 May 2022.

In open-market terms, that means 8 purchases worth €61k on one side and 11 sales worth €780k on the other. On balance, insiders were net sellers of €719k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants and 11 option exercises. Since January 2022: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €4,085.

The record was last updated on 1 June 2022 with an option exercise (€33k) in Milestone Pharmaceuticals Inc. The clock since the last published purchase (1 June 2022) now reads 1,605 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.